Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 7/10/20 Advocacy at a Glance STEVEN GROSSMAN 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More Advocacy at a Glance STEVEN GROSSMAN 6/22/18 Advocacy at a Glance STEVEN GROSSMAN 6/22/18 Still Time to Join the Alliance’s Sign-on Letter in Support of FDA Funding Read More Advocacy at a Glance STEVEN GROSSMAN 6/8/18 Advocacy at a Glance STEVEN GROSSMAN 6/8/18 FDA Funding Likely to Reach House, then Senate Floor as Part of a Mini-bus Read More Advocacy at a Glance STEVEN GROSSMAN 10/6/17 Advocacy at a Glance STEVEN GROSSMAN 10/6/17 House Passes FY 18 Budget Resolution; Differs from Senate Version and more Read More Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Advocacy at a Glance STEVEN GROSSMAN 5/8/21 Hill Days focusing on Senate staff on May 25 and 26. Alliance webinars upcoming with CDER Director Cavazzoni and FDA’s food and animal health leadership. Read More
Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Advocacy at a Glance STEVEN GROSSMAN 3/19/21 Secretary Becerra was confirmed this week and faces a large and pressing set of responsibilities. Read More
Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Advocacy at a Glance STEVEN GROSSMAN 10/24/20 Washington Is Waiting for the Election Read More
Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Advocacy at a Glance STEVEN GROSSMAN 10/16/20 Congressional Committees Overseeing FDA Will Have Some Changes in the New Congress Read More
Advocacy at a Glance STEVEN GROSSMAN 7/18/20 Advocacy at a Glance STEVEN GROSSMAN 7/18/20 House to Consider FY 21 Minibus that Contains Ag/FDA Funding, Scheduled for Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 7/10/20 Advocacy at a Glance STEVEN GROSSMAN 7/10/20 House Appropriations Committee Votes for $41 Million Increase for FDA in FY 21 Read More
Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More
Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Advocacy at a Glance STEVEN GROSSMAN 4/24/20 Appropriations Committees Still Have No Schedule; House Rules Do Not Permit Remote Mark-ups Read More
Analysis and Commentary STEVEN GROSSMAN 4/17/20 Analysis and Commentary STEVEN GROSSMAN 4/17/20 The COVID-19 Pandemic and Maintenance of a Continued Safe Food Supply Read More
Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Advocacy at a Glance STEVEN GROSSMAN 4/17/20 Congress Out Until at Least May 4; Not Clear How Work Will Be Done Read More
Advocacy at a Glance STEVEN GROSSMAN 3/27/20 Advocacy at a Glance STEVEN GROSSMAN 3/27/20 FDA Gains $80 Million in Third Pandemic Relief Bill Read More
Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More
Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More
Advocacy at a Glance STEVEN GROSSMAN 5/10/19 Advocacy at a Glance STEVEN GROSSMAN 5/10/19 No Budget Agreement: House Moves Forward, Senate Waits Read More
Advocacy at a Glance STEVEN GROSSMAN 6/22/18 Advocacy at a Glance STEVEN GROSSMAN 6/22/18 Still Time to Join the Alliance’s Sign-on Letter in Support of FDA Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 6/8/18 Advocacy at a Glance STEVEN GROSSMAN 6/8/18 FDA Funding Likely to Reach House, then Senate Floor as Part of a Mini-bus Read More
Advocacy at a Glance STEVEN GROSSMAN 10/6/17 Advocacy at a Glance STEVEN GROSSMAN 10/6/17 House Passes FY 18 Budget Resolution; Differs from Senate Version and more Read More
Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Advocacy at a Glance STEVEN GROSSMAN 9/29/17 Ever Wonder What FDA Was Like A Decade Ago and more Read More
Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Advocacy at a Glance STEVEN GROSSMAN 7/21/17 Senate Appropriations Committee Votes for FY 18 FDA Funding at FY 17 Levels and more Read More
